Skip to main content

Month: July 2021

Mass Megawatts Increases its Manufacturing Capabilities for Solar Tracker Production

WORCESTER, Mass., July 30, 2021 (GLOBE NEWSWIRE) — Mass Megawatts Wind Power, Inc. (OTC Pink: MMMW) announces its increased ability to manufacture and improve the delivery of a small and steady amount of solar tracker sales.  Much of the additional equipment in the delivery of its product is existing equipment of small production companies and facilities in Massachusetts.  Using the equipment during the nights and weekends when it would not ordinarily be used by the other companies gives an additional source of revenue to the owners of the equipment and avoids capital expenditures by Mass Megawatts. The ability to use other equipment improves the ability to maintain a sufficient cash flow for delivering sales. At some point in the future with an anticipated larger amount of sales, Mass Megawatts plans to have its own equipment...

Continue reading

Uxin Reports Fourth Quarter and Fiscal Year 2021 Financial Results

BEIJING, July 30, 2021 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading nationwide online used car dealer in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended March 31, 2021. Uxin Fiscal Year Ended March 31, 2021 Annual Letter to Shareholders Dear Shareholders, On behalf of Uxin Limited, I would like to express my sincere appreciation for your longstanding trust and support. In this annual shareholder letter, I am pleased to provide updates on our business performance and some of our achievements over the past twelve months. Uxin turned 10 years old in 2021, which is also a year of great significance for our company. In a challenging business environment reshaped by the COVID-19 pandemic, we completed a series of upgrades and adjustments to our...

Continue reading

Imara to Webcast Conference Call of Second Quarter 2021 Financial Results and Business Highlights

BOSTON, July 30, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the company will host a conference call and live webcast on Friday, August 6, 2021, at 8:30 a.m. ET to discuss its financial results for the quarter ended June 30, 2021 and review recent business highlights. A live webcast will be available under “Events and Presentations” in the Investors section of the company’s website. The conference call can be accessed by dialing 1 (833) 519-1307 (U.S. domestic) or +1 (914) 800-3873 (international) and referring to conference ID 6499377. A replay of the webcast will be archived on the Imara website following the...

Continue reading

Verano Affiliate Announces Opening of Flagship Pittsburgh Dispensary with Western Pennsylvania’s First Drive-Through

Located at The Mall at Robinson, a high-traffic retail and hospitality destination, the free-standing dispensary is set near the intersection of I-376 and Lincoln Highway. It is also the first dispensary in Western Pennsylvania with a four-lane drive-through, offering a uniquely convenient patient experience. This is the 80th active dispensary nationwide for the Company and its affiliates. Verano anticipates opening as many as seven total dispensaries across its active, 11-state footprint, including new locations in Florida and Nevada, by the end of 2021, with an additional two Pennsylvania storefronts through affiliate Agronomed Biologics. This is the second of six permitted clinical registrant dispensary locations opened by Verano affiliate Agronomed Biologics in Pennsylvania, and the Company’s 12th affiliated, active dispensary overall...

Continue reading

Greenlane Reports Preliminary Second Quarter 2021 Financial Results

Company to Host Q2 2021 Conference call August 17, 2021, at 8:30am ET BOCA RATON, Fla., July 30, 2021 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), a global house of brands and one of the largest sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced preliminary financial results for its second quarter ended June 30, 2021. Preliminary Estimated and Unaudited Q2 2021 Financial and Other Data: On a preliminary (unaudited) basis, the Company anticipates:Net sales of approximately $34.5 million Gross margin of 21% to 22% Total cash balance of approximately $11.5 millionPrimarily due to headwinds created by uncertainty in our supply chain and lingering impacts of Covid-19, the Company is suspending the illustrative...

Continue reading

Cerevel Therapeutics Announces Redemption of Public Warrants

CAMBRIDGE, Mass., July 30, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that on August 30, 2021 at 5:00 p.m. ET, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement, dated as of June 9, 2020, by and between the Company (f/k/a ARYA Sciences Acquisition Corp II) and Continental Stock Transfer & Trust Company (“Continental”), as warrant agent. Each such public warrant may be exercised by the holder thereof to purchase one share of the Company’s common stock at the exercise price of $11.50 per public warrant. Any such public warrants that remain unexercised following 5:00 p.m. ET on August...

Continue reading

Green Thumb Industries to Open Rise Salem in Virginia, Its 60th Retail Location in the Nation, on August 2

CHICAGO and SALEM, Va., July 30, 2021 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ Dispensaries, today announced it will open Rise Salem, the Company’s second retail location in Virginia and 60th store nationwide, on Monday, August 2nd. Profits from the first day of sales will be donated to a local non-profit organization. “We are excited to open the first Rise™ location in Virginia and our first store in a southeastern state,” said Green Thumb Founder and Chief Executive Officer Ben Kovler. “As cannabis acceptance sweeps the country, we are honored to expand our retail footprint and to be the first medical cannabis dispensary in the Roanoke region. We look forward to meeting more community members and introducing...

Continue reading

Balchem Corporation Reports Record Second Quarter Sales of $202.4 Million, Net Earnings of $22.7 Million, GAAP EPS of $0.70, and Adjusted EPS of $0.93

NEW HAMPTON, N.Y., July 30, 2021 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today record second quarter net earnings of $22.7 million for 2021, compared to net earnings of $21.1 million for the second quarter 2020, adjusted net earnings(a) of $30.4 million, compared to $27.6 million in the prior year quarter, and adjusted EBITDA(a) of $50.1 million, compared to $43.9 million in the prior year quarter. Second Quarter 2021 Financial Highlights:Net sales were $202.4 million, an increase of $29.0 million, or 16.7%, compared to the prior year quarter, with record sales in all three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Adjusted EBITDA was $50.1 million, an increase of $6.3 million, or 14.3%, from the prior year. GAAP net earnings were $22.7 million, an increase...

Continue reading

WisdomTree Announces Second Quarter 2021 Results – Diluted Earnings Per Share of $0.11 ($0.10, as adjusted)

NEW YORK, July 30, 2021 (GLOBE NEWSWIRE) — WisdomTree Investments, Inc. (NASDAQ: WETF) today reported financial results for the second quarter of 2021. $17.6 million net income ($16.81 million net income, as adjusted), see “Non-GAAP Financial Measurements” for additional information. $73.9 billion of ending AUM, an increase of 6.3% arising from market appreciation and net inflows. $0.9 billion of net inflows, driven by inflows into our emerging markets equity, international developed market equity, U.S. equity and fixed income products. 0.41% average global advisory fee, a decrease of 1 basis point due to AUM mix shift. $77.6 million of operating revenues, an increase of 6.6% due to higher average AUM, partly offset by a lower average global advisory fee.                                                                                                                                                        ...

Continue reading

Capital Product Partners L.P. Announces Second Quarter 2021 Financial Results

ATHENS, Greece, July 30, 2021 (GLOBE NEWSWIRE) — Capital Product Partners L.P. (the “Partnership”, “CPLP” or “we” / “us”) (NASDAQ: CPLP), an international owner of ocean-going vessels, today released its financial results for the second quarter ended June 30, 2021. Highlights Three-month periods ended June 30,    2021 2020 IncreaseRevenues $39.8 million $36.6 million 9%Expenses $25.6 million $22.7 million 13%Net Income $35.4 million $8.7 million 307%Net Income per common unit $1.89 $0.46 311%Operating Surplus1 and Operating Surplus after the quarterly allocation to the capital reserve for the second quarter of 2021 were $23.5 million and $15.2 million, respectively. Announced common unit distribution of $0.10 for the second quarter of 2021. Repurchased 331,214 of the Partnership’s common units during the six...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.